Aortic-valve stenosis—from patients at risk to severe valve obstruction
CM Otto, B Prendergast - New England Journal of Medicine, 2014 - Mass Medical Soc
Aortic-Valve Stenosis — From Patients at Risk to Severe Valve Obstruction | New England Journal
of Medicine Skip to main content Access provided by Charite - Universitaetsmedizin Berlin The …
of Medicine Skip to main content Access provided by Charite - Universitaetsmedizin Berlin The …
[HTML][HTML] Aortic stenosis: diagnosis and treatment
BH Grimard, RE Safford, EL Burns - American family physician, 2016 - aafp.org
Aortic stenosis affects 3% of persons older than 65 years. Although survival in asymptomatic
patients is comparable to that in age-and sex-matched control patients, it decreases rapidly …
patients is comparable to that in age-and sex-matched control patients, it decreases rapidly …
Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study
RLJ Osnabrugge, D Mylotte, SJ Head… - Journal of the American …, 2013 - jacc.org
Objectives: The purpose of this study was to evaluate the prevalence of aortic stenosis (AS)
in the elderly and to estimate the current and future number of candidates for transcatheter …
in the elderly and to estimate the current and future number of candidates for transcatheter …
Incidence, predictors, and outcomes of permanent pacemaker implantation following transcatheter aortic valve replacement: analysis from the US Society of Thoracic …
OO Fadahunsi, A Olowoyeye, A Ukaigwe, Z Li… - JACC: Cardiovascular …, 2016 - jacc.org
Objectives: The purpose of this study was to evaluate the incidence, predictors, and clinical
outcomes of permanent pacemaker (PPM) implantation following transcatheter aortic valve …
outcomes of permanent pacemaker (PPM) implantation following transcatheter aortic valve …
Cost-effectiveness of transcatheter versus surgical aortic valve replacement in patients with severe aortic stenosis at intermediate risk: results from the PARTNER 2 …
SJ Baron, K Wang, JA House, EA Magnuson… - Circulation, 2019 - Am Heart Assoc
Background: In patients with severe aortic stenosis (AS) at intermediate surgical risk,
treatment with transcatheter aortic valve replacement (TAVR) or surgical aortic valve …
treatment with transcatheter aortic valve replacement (TAVR) or surgical aortic valve …
Long-term outcomes in patients with new permanent pacemaker implantation following transcatheter aortic valve replacement
C Chamandi, M Barbanti, A Munoz-Garcia… - JACC: Cardiovascular …, 2018 - jacc.org
Objectives: This study sought to evaluate the long-term clinical impact of permanent
pacemaker implantation (PPI) after transcatheter aortic valve replacement (TAVR) …
pacemaker implantation (PPI) after transcatheter aortic valve replacement (TAVR) …
Thirty-day readmissions after transcatheter aortic valve replacement in the United States: insights from the nationwide readmissions database
Background—Readmissions after cardiac procedures are common and contribute to
increased healthcare utilization and costs. Data on 30-day readmissions after transcatheter …
increased healthcare utilization and costs. Data on 30-day readmissions after transcatheter …
Transcatheter aortic valve replacement in Europe: adoption trends and factors influencing device utilization
D Mylotte, RLJ Osnabrugge, S Windecker… - Journal of the American …, 2013 - jacc.org
Objectives: The authors sought to examine the adoption of transcatheter aortic valve
replacement (TAVR) in Western Europe and investigate factors that may influence the …
replacement (TAVR) in Western Europe and investigate factors that may influence the …
Cost-effectiveness of transcatheter aortic valve replacement with a self-expanding prosthesis versus surgical aortic valve replacement
MR Reynolds, Y Lei, K Wang… - Journal of the American …, 2016 - jacc.org
Background: Previous studies of the cost-effectiveness of transcatheter aortic valve
replacement (TAVR) have been based primarily on a single balloon-expandable system …
replacement (TAVR) have been based primarily on a single balloon-expandable system …
[PDF][PDF] Optimising patient discharge management after transfemoral transcatheter aortic valve implantation: the multicentre European FAST-TAVI trial
M Barbanti, MS van Mourik, MS Spence… - …, 2019 - researchgate.net
Aims: Treatment pathway optimisation in TAVI should include timely patient discharge with a
minimised risk for out-of-hospital adverse events. The aim of this study was to define a …
minimised risk for out-of-hospital adverse events. The aim of this study was to define a …